We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL11 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
981.3
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
3838.1
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
2997.7
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
2879.2
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
2676.4
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
2639.1
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
2561.3
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
2534.5
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
2497.5
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
2351.3
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
2322.2
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
2286.4
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
2263.6
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
2206.7
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
2172.6
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
2146.0
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
2133.2
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
2127.0
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
2068.7
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
1982.5
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1969.4
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
1966.6
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
1928.7
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
1901.2
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
1879.2
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
1874.3
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
1801.2
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
1778.4
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
1768.9
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
1765.9
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
1761.1
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
1722.2
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
1712.7
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
1683.1
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
1680.5
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
1638.7
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
1618.2
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
1612.5
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
1602.6
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
1569.6
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
1549.3
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
1543.8
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
1535.2
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
1523.4
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
1514.7
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
1497.3
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
1494.2
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
1486.9
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
1478.4
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
1475.4
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
1467.8
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
1461.3
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
1455.9
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
1454.5
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
1449.3
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
1440.7
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
1420.3
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
1403.4
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
1400.4
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
1397.8
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
1383.9
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
1376.0
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
1362.9
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
1361.7
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
1350.2
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
1349.5
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
1343.3
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
1343.2
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
1323.8
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
1310.6
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
1294.6
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
1294.1
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
1293.5
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
1291.7
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
1284.4
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
1284.3
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
1282.1
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
1279.5
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
1277.8
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
1258.8
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
1249.6
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
1244.6
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
1242.9
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1232.6
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
1228.3
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
1223.0
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
1206.5
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
1203.8
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
1200.8
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
1194.9
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
1187.1
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1184.2
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
1181.9
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
1177.5
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
1167.4
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
1166.5
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
1162.7
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
1160.9
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1156.9
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
1153.1
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
1136.4
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
1132.8
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1129.2
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
1128.7
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
1123.3
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
1120.7
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
1117.8
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
1112.3
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
1109.9
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
1109.0
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
1101.8
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
1095.5
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
1091.9
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
1091.0
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
1089.3
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
1088.8
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
1071.2
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1069.3
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
1068.5
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
1057.7
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
1054.8
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
1050.7
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
1050.4
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
1049.3
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
1046.2
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
1039.8
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
1023.0
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
1020.7
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
1020.3
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
1015.6
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
1012.4
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
1005.5
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
999.6
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
998.7
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
990.8
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
985.0
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
977.1
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
970.1
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
967.4
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
964.7
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
955.2
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
951.7
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
946.1
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
935.3
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
934.1
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
932.2
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
930.4
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
930.3
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
929.4
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
923.1
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
922.9
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
915.5
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
913.8
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
906.7
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
904.6
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
903.7
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
901.3
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
885.3
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
878.0
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
876.1
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
874.3
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
870.7
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
866.8
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
863.9
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
860.4
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
858.7
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
853.3
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
852.9
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
851.6
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
848.1
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
847.4
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
845.1
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
844.4
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
843.8
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
840.2
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
836.0
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
834.9
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
831.2
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
829.4
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
825.8
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
821.9
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
821.4
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
813.5
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
813.4
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
813.4
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
811.9
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
811.9
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
808.3
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
803.1
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
789.0
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
787.5
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
785.4
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
777.1
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
770.1
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
768.4
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
768.0
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
767.4
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
765.0
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
762.3
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
761.4
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
759.9
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
752.1
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
751.2
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
750.4
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
750.1
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
747.3
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
746.9
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
737.9
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
737.7
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
736.6
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
731.0
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
730.2
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
727.5
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
725.6
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
724.3
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
721.0
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
719.3
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
718.2
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
716.1
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
714.8
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
710.7
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
710.5
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
705.3
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
705.1
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
702.8
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
694.8
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
694.1
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
690.1
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
689.9
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
689.0
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
688.5
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
687.7
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
681.5
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
679.3
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
678.7
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
677.8
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
676.0
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
674.6
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
672.8
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
671.7
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
671.4
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
671.1
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
670.6
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
669.1
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
667.7
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
666.0
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
665.4
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
664.2
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
660.4
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
659.4
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
655.3
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
652.7
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
650.9
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
648.8
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
646.8
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
644.0
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
639.6
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
639.4
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
636.2
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
636.1
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
635.3
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
632.0
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
631.8
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
629.8
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
629.4
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
629.4
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
628.7
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
628.5
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
626.7
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
620.2
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
617.3
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
616.5
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
616.4
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
612.1
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
609.5
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
607.8
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
602.4
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
601.8
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
600.1
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
593.9
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
588.6
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
587.3
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
584.6
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
584.3
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
579.0
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
578.5
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
577.3
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
577.1
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
576.0
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
573.8
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
564.8
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
561.8
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
553.3
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
549.6
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
545.9
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
543.7
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
542.8
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
542.6
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
542.4
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
538.5
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
537.2
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
537.0
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
528.4
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
521.4
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
520.9
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
520.4
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
520.4
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
517.7
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
515.1
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
507.4
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
506.9
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
502.8
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
500.4
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
500.3
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
498.8
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
493.2
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
491.5
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
489.6
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
489.3
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
486.4
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
484.6
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
465.7
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
462.7
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
453.6
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
452.6
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
445.9
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
439.6
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
439.1
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
433.5
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
432.6
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
417.9
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
415.5
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
411.6
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
404.2
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
399.6
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
393.5
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
393.1
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
390.9
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
387.9
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
381.3
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
376.1
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
374.1
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
373.7
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
365.4
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
365.3
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
362.1
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
357.8
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
354.7
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
294.1
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL11 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2848.0
Number of samples
81
Samples
Sample
Description
TPM
DO46390
65 years, female, NA, stage:III, dead, 374 days
6368.3
DO46384
55 years, female, NA, stage:III, dead, 614 days
6249.1
DO46370
54 years, female, NA, stage:III, dead, 1727 days
5982.0
DO46463
49 years, female, NA, stage:III, dead, 2451 days
5747.4
DO46342
67 years, female, NA, stage:III, dead, 1398 days
4807.1
DO46392
48 years, female, NA, stage:III, dead, 628 days
4791.7
DO46380
51 years, female, NA, stage:III, dead, 1423 days
4645.0
DO46333
58 years, female, NA, stage:III, dead, 359 days
4603.1
DO46518
62 years, female, NA, stage:III, alive, 2960 days
4492.8
DO46561
52 years, female, NA, stage:III, dead, 195 days
4468.5
DO46586
55 years, female, NA, stage:III, dead, 1019 days
4463.9
DO46356
68 years, female, NA, stage:III, dead, 911 days
4220.2
DO46591
58 years, female, NA, stage:III, dead, 195 days
4124.2
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
4112.2
DO46581
66 years, female, NA, stage:III, dead, 408 days
3985.6
DO46398
66 years, female, NA, stage:III, alive, 437 days
3765.6
DO46331
72 years, female, NA, stage:III, dead, 612 days
3752.5
DO46338
59 years, female, NA, stage:III, dead, 596 days
3631.4
DO46576
75 years, female, NA, stage:III, alive, 133 days
3617.3
DO46566
78 years, female, NA, stage:III, dead, 673 days
3607.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
3411.7
DO46364
45 years, female, NA, stage:III, dead, 806 days
3333.0
DO46352
60 years, female, NA, stage:III, dead, 677 days
3277.0
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
3193.4
DO46402
77 years, female, NA, stage:III, dead, 511 days
3156.0
DO46602
74 years, female, NA, stage:III, dead, 205 days
3096.0
DO46408
56 years, female, NA, stage:III, dead, 489 days
3031.6
DO46328
52 years, female, NA, stage:III, dead, 972 days
2969.4
DO46453
66 years, female, NA, stage:III, dead, 3294 days
2938.8
DO46326
51 years, female, NA, stage:III, dead, 701 days
2893.5
DO46508
50 years, female, NA, stage:III, dead, 2101 days
2858.2
DO46560
45 years, female, NA, stage:IV, dead, 286 days
2838.4
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2805.5
DO46400
70 years, female, NA, stage:III, dead, 719 days
2775.3
DO46386
49 years, female, NA, stage:III, dead, 1162 days
2738.8
DO46404
55 years, female, NA, stage:III, dead, 690 days
2716.2
DO46329
52 years, female, NA, stage:III, dead, 1699 days
2676.2
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
2664.2
DO46448
45 years, female, NA, stage:III, dead, 654 days
2647.7
DO46346
54 years, female, NA, stage:III, dead, 1187 days
2603.8
DO46374
69 years, female, NA, stage:III, dead, 1409 days
2593.7
DO46354
73 years, female, NA, stage:III, dead, 843 days
2562.2
DO46372
39 years, female, NA, stage:III, dead, 1326 days
2559.2
DO46350
66 years, female, NA, stage:III, dead, 886 days
2548.9
DO46366
65 years, female, NA, stage:III, dead, 2054 days
2529.3
DO46533
46 years, female, NA, stage:III, alive, 3667 days
2521.8
DO46443
59 years, female, NA, stage:III, dead, 2464 days
2499.2
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
2483.4
DO46568
66 years, female, NA, stage:III, dead, 320 days
2482.7
DO46334
77 years, female, NA, stage:III, dead, 496 days
2481.5
DO46396
64 years, female, NA, stage:III, dead, 583 days
2447.7
DO46330
60 years, female, NA, stage:III, dead, 684 days
2400.1
DO46436
58 years, female, NA, stage:III, alive, 3193 days
2392.3
DO46362
61 years, female, NA, stage:III, dead, 1639 days
2339.4
DO46378
59 years, female, NA, stage:III, alive, 843 days
2324.7
DO46597
60 years, female, NA, stage:III, dead, 393 days
2311.8
DO46412
64 years, female, NA, stage:III, dead, 597 days
2271.4
DO46468
67 years, female, NA, stage:III, alive, 2776 days
2258.1
DO46493
62 years, female, NA, stage:IV, alive, 839 days
2255.9
DO46325
54 years, female, NA, stage:III, dead, 477 days
2231.9
DO46611
52 years, female, NA, stage:III, dead, 734 days
2093.6
DO46551
58 years, female, NA, stage:III, dead, 1055 days
2068.2
DO46336
70 years, female, NA, stage:IV, dead, 664 days
1841.8
DO46358
60 years, female, NA, stage:III, dead, 423 days
1777.8
DO46571
61 years, female, NA, stage:III, dead, 243 days
1765.8
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1761.4
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
1674.3
DO46332
56 years, female, NA, stage:III, dead, 689 days
1651.9
DO46432
56 years, female, NA, stage:III, alive, 2218 days
1629.1
DO46388
74 years, female, NA, stage:III, dead, 413 days
1498.3
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1479.8
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1453.2
DO46606
73 years, female, NA, stage:III, alive, 804 days
1448.0
DO46368
57 years, female, NA, stage:III, dead, 2879 days
1445.4
DO46327
54 years, female, NA, stage:III, dead, 184 days
1434.4
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1410.7
DO46340
62 years, female, NA, stage:III, dead, 616 days
1381.9
DO46348
58 years, female, NA, stage:IV, dead, 287 days
1373.5
DO46344
46 years, female, NA, stage:III, dead, 642 days
1158.9
DO46588
74 years, female, NA, stage:III, dead, 438 days
934.9
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
850.4
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.3
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.3
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.4
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.5
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.5
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.5
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.6
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.6
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.6
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.6
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.7
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.7
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.7
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.7
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.7
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.7
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.7
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.8
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.8
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.8
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.8
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.8
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.8
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.8
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.9
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.9
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.9
15524912-685a-47ce-a824-567848_D2
Tumor
-0.9
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.9
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.9
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-1.0
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-1.0
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-1.0
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-1.0
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-1.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-1.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-1.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-1.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-1.1
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-1.1
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-1.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-1.1
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-1.2
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-1.2
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-1.2
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-1.2
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-1.2
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-1.2
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-1.3
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-1.3
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-1.3
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-1.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-1.3
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-1.3
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-1.4
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-1.4
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-1.4
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-1.4
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-1.4
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-1.4
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-1.4
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-1.4
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-1.4
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-1.4
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-1.4
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-1.4
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-1.5
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-1.5
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-1.5
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-1.5
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-1.5
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-1.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-1.5
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-1.5
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-1.6
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-1.6
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-1.6
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-1.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-1.6
e9d416e7-f661-400a-896e-388545_D2
Tumor
-1.6
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-1.6
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-1.6
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-1.6
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-1.6
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-1.6
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-1.7
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-1.7
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-1.7
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-1.7
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-1.7
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-1.7
285fed94-1495-448e-879b-b55de9_D2
Tumor
-1.7
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-1.7
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-1.7
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-1.7
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-1.7
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-1.8
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-1.8
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-1.8
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-1.8
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-1.9
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-1.9
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-1.9
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-2.0
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-2.0
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-2.1
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
